Practical Guidance for MedTech Reimbursement and Market Access
Insight on what matters most, and what it all means for your next milestone.
Is it Getting Much Harder to Obtain Your Own Code? What Recent Data Suggests
The 2025 AMA CPT Editorial Panel shows declining code approvals. Discover what this means for MedTech innovators and how to strengthen your coding strategy. ...more
Coding and Payment ,Commercialization
October 31, 2025•2 min read
Is an NCD the Right Move for Your Technology? Lessons from CMS’s Final Decision on Renal Denervation
Learn when to pursue a National Coverage Determination (NCD) and what CMS’s renal denervation decision means for MedTech reimbursement and evidence strategy. ...more
Payer Coverage ,Evidence Planning &Commercialization
October 29, 2025•5 min read
Why FDA Approval Isn’t Enough for Payer Coverage
FDA approval doesn’t guarantee insurance payment. Learn why payers reject FDA-cleared devices—and how startups can align early with reimbursement strategies. ...more
Payer Coverage
October 06, 2025•5 min read
Why a Payer Dossier Matters, Even in the Early Days
Discover why payer dossiers are critical for MedTech startups, even in early stages. Learn how they guide evidence development, coding, and reimbursement strategy. ...more
Payer Coverage ,Evidence Planning
September 16, 2025•4 min read
Introduction to Temporary Payments for New Devices
Learn how NTAP, TPT, and NT-APC help MedTech startups bridge the gap between FDA clearance and permanent reimbursement. Early payment can drive adoption. ...more
Coding and Payment
September 11, 2025•4 min read
Featured Insights for MedTech Innovators
Insights to help you validate your pathway, align with payer expectations, and move forward with confidence.
Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it. ...more
Coding and Payment ,Evidence Planning &Featured
March 19, 2025•4 min read
Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms
New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know. ...more
Coding and Payment ,Commercialization &Featured
March 04, 2025•3 min read
The Hidden Bias in Reimbursement: Why First Movers May Have It Easier
Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than ... ...more
Coding and Payment ,Evidence Planning Fundamentals &Featured
February 06, 2025•4 min read
The World After FDA Clearance: From HOORAY! To WAIT, WHAT?
FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after. ...more
Commercialization ,Fundamentals &Featured
August 20, 2024•5 min read
How Hospital Financial Decisions Shape the Fate of New MedTech Innovations
Hospitals are the gatekeepers of device adoption. Learn how to align with their economics. ...more
Commercialization ,Fundamentals &Featured
August 07, 2024•4 min read
Relearning English When it Comes to FDA and CMS Jargon
MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement. ...more
Fundamentals ,Featured
June 04, 2024•1 min read
Helping MedTech innovators achieve widespread reimbursement coverage in the U.S.
© 2025 Coustier Advisory LLC. All rights reserved.
Powered by Rocket Boost